Table 3:

Recommendations from the Common Drug Review and pan-Canadian Oncology Drug Review

No. of drugs that received a recommendation; classification			No. of drugs that did not receive a recommendation; reason

List in formulary in a manner similar to other drugs in the same class	List subject to conditions	Do not list^*	Approved before start of CDR or pCODR	Other^†
1	12	13	23	7

Note: CDR = Common Drug Review, pCODR = pan-Canadian Oncology Drug Review.
↵* For 1 of these drugs, the recommendation was that the drug not be listed at the price submitted by the company.
↵† Reason not available.